These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 27906457)

  • 1. Comparison of Survival Times for Dogs with Pituitary-Dependent Hyperadrenocorticism in a Primary-Care Hospital: Treated with Trilostane versus Untreated.
    Nagata N; Kojima K; Yuki M
    J Vet Intern Med; 2017 Jan; 31(1):22-28. PubMed ID: 27906457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of 2 trilostane protocols for the treatment of canine pituitary-dependent hyperadrenocorticism: twice daily versus once daily.
    Arenas C; Melián C; Pérez-Alenza MD
    J Vet Intern Med; 2013; 27(6):1478-85. PubMed ID: 24118316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of factors that influence survival in dogs with adrenal-dependent hyperadrenocorticism treated with mitotane or trilostane.
    Helm JR; McLauchlan G; Boden LA; Frowde PE; Collings AJ; Tebb AJ; Elwood CM; Herrtage ME; Parkin TD; Ramsey IK
    J Vet Intern Med; 2011; 25(2):251-60. PubMed ID: 21352377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of low- and high-dose trilostane treatment in dogs (< 5 kg) with pituitary-dependent hyperadrenocorticism.
    Cho KD; Kang JH; Chang D; Na KJ; Yang MP
    J Vet Intern Med; 2013; 27(1):91-8. PubMed ID: 23167780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term efficacy of trilostane administered twice daily in dogs with pituitary-dependent hyperadrenocorticism.
    Alenza DP; Arenas C; Lopez ML; Melian C
    J Am Anim Hosp Assoc; 2006; 42(4):269-76. PubMed ID: 16822765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of trilostane on hormone and serum electrolyte concentrations in dogs with pituitary-dependent hyperadrenocorticism.
    Griebsch C; Lehnert C; Williams GJ; Failing K; Neiger R
    J Vet Intern Med; 2014; 28(1):160-5. PubMed ID: 24341822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of dogs with pituitary-dependent hyperadrenocorticism treated twice daily with low doses of trilostane.
    García San José P; Arenas Bermejo C; Alonso-Miguel D; González Sanz S; Clares Moral I; Portero Fuentes M; Pérez-Alenza MD
    Vet Rec; 2022 Aug; 191(3):e1630. PubMed ID: 35460587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the survival times of dogs treated with mitotane or trilostane for pituitary-dependent hyperadrenocorticism.
    Barker EN; Campbell S; Tebb AJ; Neiger R; Herrtage ME; Reid SW; Ramsey IK
    J Vet Intern Med; 2005; 19(6):810-5. PubMed ID: 16355673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum concentrations of cortisol and cortisone in healthy dogs and dogs with pituitary-dependent hyperadrenocorticism treated with trilostane.
    Sieber-Ruckstuhl NS; Boretti FS; Wenger M; Maser-Gluth C; Reusch CE
    Vet Rec; 2008 Oct; 163(16):477-81. PubMed ID: 18931355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival of dogs with adrenal-dependent hyperadrenocorticism: a comparison between mitotane and twice daily trilostane treatment.
    Arenas C; Melián C; Pérez-Alenza MD
    J Vet Intern Med; 2014; 28(2):473-80. PubMed ID: 24495125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of non-selective adrenocorticolysis with mitotane or trilostane for the treatment of dogs with pituitary-dependent hyperadrenocorticism.
    Clemente M; De Andrés PJ; Arenas C; Melián C; Morales M; Pérez-Alenza MD
    Vet Rec; 2007 Dec; 161(24):805-9. PubMed ID: 18083978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trilostane treatment in dogs with pituitary-dependent hyperadrenocorticism.
    Braddock JA; Church DB; Robertson ID; Watson AD
    Aust Vet J; 2003 Oct; 81(10):600-7. PubMed ID: 15080470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on the use of trilostane in dogs.
    Lemetayer J; Blois S
    Can Vet J; 2018 Apr; 59(4):397-407. PubMed ID: 29606727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortisol, aldosterone, cortisol precursor, androgen and endogenous ACTH concentrations in dogs with pituitary-dependant hyperadrenocorticism treated with trilostane.
    Sieber-Ruckstuhl NS; Boretti FS; Wenger M; Maser-Gluth C; Reusch CE
    Domest Anim Endocrinol; 2006 Jul; 31(1):63-75. PubMed ID: 16233969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors for survival in dogs with pituitary-dependent hypercortisolism treated with trilostane.
    Fracassi F; Corradini S; Floriano D; Boari A; Aste G; Pietra M; Bergamini PF; Dondi F
    Vet Rec; 2015 Jan; 176(2):49. PubMed ID: 25170036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory assessment of trilostane treatment in dogs with pituitary-dependent hyperadrenocorticism.
    Arenas Bermejo C; Pérez Alenza D; García San José P; Llauet L; Pérez-López L; Melián C; C Feldman E
    J Vet Intern Med; 2020 Jul; 34(4):1413-1422. PubMed ID: 32533623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of twice-daily lower-dose trilostane treatment administered orally in dogs with naturally occurring hyperadrenocorticism.
    Feldman EC
    J Am Vet Med Assoc; 2011 Jun; 238(11):1441-51. PubMed ID: 21627507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of clinical examinations, laboratory tests, and ultrasonography in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane.
    Ruckstuhl NS; Nett CS; Reusch CE
    Am J Vet Res; 2002 Apr; 63(4):506-12. PubMed ID: 11939311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cholecystokinin concentrations in dogs with naturally acquired pituitary-dependent hyperadrenocorticism.
    Noh S; Kim HS; Chang J; Kang JH; Chang D; Yang MP
    Am J Vet Res; 2016 Oct; 77(10):1101-7. PubMed ID: 27668581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of trilostane on the pituitary-adrenocortical and renin-aldosterone axis in dogs with pituitary-dependent hypercortisolism.
    Galac S; Buijtels JJCWM; Mol JA; Kooistra HS
    Vet J; 2010 Jan; 183(1):75-80. PubMed ID: 19042143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.